Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol-beclomethasone versus placebo for cough and quality of life in adults with bronchiectasis
NL-OMON50523Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of formoterol and beclomethasone in bronchiectasis (2 arms), sponsored by Erasmus MC. Primary endpoint: Leicester Cough Questionnaire. Started Jan 2019; status: active, not recruiting.
02
Drugs
formoterolbeclomethasone
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NL-OMON50523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50523.